Published in Ann Rheum Dis on June 01, 1985
Cohort profile: the Tromso Study. Int J Epidemiol (2011) 3.29
How to diagnose axial spondyloarthritis early. Ann Rheum Dis (2004) 2.91
Ankylosing spondylitis: an overview. Ann Rheum Dis (2002) 2.71
Rheumatic diseases in China. Arthritis Res Ther (2008) 2.07
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study. Ann Rheum Dis (2013) 1.81
Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann Rheum Dis (2004) 1.49
Ankylosing spondylitis: recent breakthroughs in diagnosis and treatment. J Can Chiropr Assoc (2007) 1.34
Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches. Arthritis Res (2002) 1.21
Four cases of ankylosing spondylitis in medieval skeletal series from Croatia. Rheumatol Int (2011) 1.12
Referral strategies for early diagnosis of axial spondyloarthritis. Nat Rev Rheumatol (2012) 1.08
Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria. Clin Rheumatol (2007) 1.01
Epidemiology of spondyloarthritis. Rheum Dis Clin North Am (2012) 1.01
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci (2013) 0.93
HLA-B27 and spondyloarthropathy: value for early diagnosis? J Med Genet (1995) 0.92
[Structures of acute rheumatic care]. Z Rheumatol (2006) 0.89
Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis--a population-based longitudinal follow-up study. PLoS One (2013) 0.89
New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy. Ann Rheum Dis (2001) 0.86
Ankylosing spondylitis: from cells to genes. Int J Inflam (2013) 0.86
Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey. Clin Rheumatol (2006) 0.84
An epidemiological study on ankylosing spondylitis in southern Albania. Mater Sociomed (2014) 0.83
Clinical and radiological presentations of late-onset spondyloarthritis. ISRN Rheumatol (2011) 0.83
Raised incidence of ankylosing spondylitis among Inuit populations could be due to high HLA-B27 association and starch consumption. Rheumatol Int (2014) 0.82
Extended dosing of etanercept 25 mg can be effective in patients with ankylosing spondylitis: a retrospective analysis. Clin Rheumatol (2010) 0.81
Increased risk of stroke among patients with ankylosing spondylitis: a population-based matched-cohort study. Rheumatol Int (2013) 0.80
The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study. Arthritis Res Ther (2015) 0.80
Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of AS. BMJ Open (2014) 0.80
The patient experience with fatigue and content validity of a measure to assess fatigue severity: qualitative research in patients with ankylosing spondylitis (AS). Health Qual Life Outcomes (2013) 0.79
Sexual dimorphism, but not testosterone itself, is responsible for ankylosing enthesitis of the ankle in B10.BR (H-2k) male mice. Ann Rheum Dis (2006) 0.79
The prevalence of moderate to severe radiographic sacroiliitis and the correlation with health status in elderly Swedish men--the MrOS study. BMC Musculoskelet Disord (2013) 0.79
Frequency of fragmented QRS in ankylosing spondylitis : a prospective controlled study. Z Rheumatol (2013) 0.79
Ankylosing spondylitis in iran; late diagnosis and its causes. Iran Red Crescent Med J (2014) 0.77
Frequency of sacroiliitis among patients with low back pain. Electron Physician (2016) 0.77
Intravitreal Triamcinolone Acetonide for Macular Edema in HLA-B27 Negative Ankylosing Spondylitis. Case Rep Ophthalmol (2010) 0.75
Is the work ability index useful to evaluate absence days in ankylosing spondylitis patients? A cross-sectional study. BMJ Open (2013) 0.75
Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1). Arthritis Rheumatol (2016) 0.75
Single nucleotide polymorphisms of ABCB1 gene and response to etanercept treatment in patients with ankylosing spondylitis in a Chinese Han population. Medicine (Baltimore) (2017) 0.75
Thoracic spinal cord herniation in a patient with long-standing ankylosing spondylitis. Eur Spine J (2010) 0.75
Clinical observations programme in SpA: disease parameters, treatment options and practical management issues. Rheumatol Int (2008) 0.75
Association of variants in 21q22 with ankylosing spondylitis in the Chinese Guangxi Zhuang population. Rheumatol Int (2014) 0.75
Early diagnosis of ankylosing spondylitis: an introduction to the newly designed Iran criteria for ankylosing spondylitis. Rheumatol Int (2012) 0.75
Ankylosing spondylitis and HL-A 27. Lancet (1973) 11.99
High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90
The Tromsø heart study. Does coffee raise serum cholesterol? N Engl J Med (1983) 4.55
Striking prevalence of ankylosing spondylitis in "healthy" w27 positive males and females. N Engl J Med (1975) 4.25
Aetiology of Ankylosing Spondylitis. Ann Rheum Dis (1949) 3.61
Measurement of back movement. Ann Rheum Dis (1969) 3.32
Grading of films for sacro-iliitis in population studies. Ann Rheum Dis (1971) 2.06
The Tromsøo heart study. Methods and main results of the cross-sectional study. Acta Med Scand (1976) 2.00
Ankylosing spondylitis in a Canadian Indian population. Ann Rheum Dis (1966) 1.27
Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23
Diagnostic value of HLA-B27 testing ankylosing spondylitis and Reiter's syndrome. Ann Intern Med (1982) 1.15
The pattern of chest and spinal mobility in ankylosing spondylitis. An objective clinical study of 106 patients. Rheumatol Rehabil (1973) 1.12
Increased risk for spondylitis stigmata in apparently healthy HL-AW27 men. Ann Intern Med (1976) 1.10
Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum (1981) 1.08
Family studies and HLA typing in ankylosing spondylitis and sacroiliitis. J Rheumatol Suppl (1977) 1.01
Measurement of spinal mobility. Ann Rheum Dis (1974) 1.00
The prevalence and nature of back pain in an industrial complex: a questionnaire and radiographic and HLA analysis. Spine (Phila Pa 1976) (1980) 0.99
The radiographic diagnosis of sacroiliitis. A comparison of different views with computed tomograms of the sacroiliac joint. Arthritis Rheum (1983) 0.92
Studies on the major histocompatibility system in patients with ankylosing spondylitis. Tissue Antigens (1975) 0.90
The prevalence of ankylosing spondylitis among B27 positive normal individuals--a reassessment. J Rheumatol (1980) 0.85
Genetic heterogeneity in primary ankylosing spondylitis. J Rheumatol (1980) 0.84
[Study of a population carrying HLA B27 antigen compared with a population without B27, in the detection of ankylosing spondylitis]. Rev Rhum Mal Osteoartic (1978) 0.84
533 Patients with ankylosing spondylitis, seen and followed in the period 1948 to 1971. Ann Rheum Dis (1973) 0.84
[Risk of developing ankylosing spondylitis in "healthy" persons positive for HLA-B27 antigen]. Acta Rhumatol (2001) 0.80
On the incidence of spondylarthritis ankylopoetica in a Norwegian county. Acta Med Scand (1952) 0.80
A hospital-based survey of radiological sacroiliitis and HLA-B27 and Cw2 in Navajo and Hopi Indians. Hum Immunol (1981) 0.80
[Epidemiologic and familial studies in 3 chronic rheumatic diseases]. Z Rheumaforsch (1969) 0.79
Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med (1976) 2.98
A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest (1974) 2.78
The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in rheumatoid arthritis. Eur J Biochem (1974) 2.02
Severe intestinal involvement in Wegener's granulomatosis: report of two cases and review of the literature. Br J Rheumatol (1998) 1.97
Antigenic and chemical characterization of non-immunoglobulin amyloid proteins. Scand J Immunol (1972) 1.97
Isolation and characterization of amyloid-related serum protein SAA as a low molecular weight protein. Scand J Immunol (1975) 1.89
Peripheral blood and intestinal lymphocyte sub-populations in Crohn's disease. Gut (1975) 1.77
The prevalence of fibromyalgia among women aged 20-49 years in Arendal, Norway. Scand J Rheumatol (1992) 1.70
Immunohistochemical studies of interleukin-2 and gamma-interferon in rheumatoid arthritis. Arthritis Rheum (1985) 1.62
Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. Amyloid (1999) 1.59
Immunological characterization of lymphocytes in synovial fluid from patients with rheumatoid arthritis. Scand J Immunol (1973) 1.59
Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease. J Clin Invest (1975) 1.52
Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol (1985) 1.47
A Danish kindred with familial amyloid cardiomyopathy revisited: identification of a mutant transthyretin-methionine111 variant in serum from patients and carriers. Am J Med (1992) 1.45
Amyloid-related serum protein SAA from three animal species: comparison with human SAA. J Immunol (1977) 1.43
Amyloid fibril protein subunit, "protein AS": distribution in tissue and serum in different clinical types of amyloidosis including that associated with myelomatosis and Waldenström's macroglobulinamia. Scand J Immunol (1973) 1.41
Interleukin-6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol (1989) 1.35
Identification and characterization of different amyloid fibril proteins in tissue sections. Scand J Immunol (1977) 1.33
An epidemiological survey of the signs and symptoms of ankylosing spondylitis. Clin Rheumatol (1985) 1.33
Unique amyloid protein subunit common to different types of amyloid fibril. Nature (1973) 1.30
A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol (1996) 1.30
New, third class of amyloid fibril protein. J Exp Med (1974) 1.25
The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR. Biochem J (1981) 1.22
An unusually large (83 amino acid residues) amyloid fibril protein AA from a patient with Waldenström's macroglobulinaemia and amyloidosis. Scand J Immunol (1980) 1.21
The association between rheumatoid arthritis and the HLA antigen DR4. Ann Rheum Dis (1983) 1.21
Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol (1983) 1.19
Detection of immunoglobulins in paraffin-embedded liver biopsies. Studies in 100 patients with special regard to immunological findings in active chronic hepatitis. Scand J Gastroenterol (1973) 1.18
Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol (2001) 1.17
The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum (1993) 1.16
Characterization of renal tissue lymphocytes in patients with interstitial nephritis. Am J Med (1981) 1.15
Chemical and clinical classification of amyloidosis 1985. Scand J Immunol (1986) 1.14
HLA DR antigens and gold toxicity. Ann Rheum Dis (1983) 1.14
Amyloid-related serum protein SAA in endotoxin-induced amyloidosis of the mink. J Exp Med (1976) 1.14
Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol (1985) 1.14
A 5.5 year prospective study of self-reported musculoskeletal pain and of fibromyalgia in a female population: significance and natural history. Clin Rheumatol (1999) 1.13
A new prealbumin variant in familial amyloid cardiomyopathy of Danish origin. Scand J Immunol (1988) 1.13
Predominance of T cells in the lymphocytic infiltrates of synovial tissues in rheumatoid arthritis. Arthritis Rheum (1976) 1.13
The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology (Oxford) (2001) 1.11
N-terminal amino acid sequence of amyloid fibril protein AR, prototype of a new lambda-variable subgroup, V lambda V. Scand J Immunol (1974) 1.10
A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum (1983) 1.08
Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol (2000) 1.07
HLA-DRw4 and rheumatoid arthritis. Lancet (1979) 1.06
Long-term follow-up after primary repair of the anterior cruciate ligament: clinical and radiological evaluation 15-23 years postoperatively. Arch Orthop Trauma Surg (2004) 1.05
Antibodies to human caudate nucleus neurons in Huntington's chorea. J Clin Invest (1977) 1.04
Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis (2001) 1.04
Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils. Scand J Immunol (1976) 1.03
An experimental model in mink for studying the relation between amyloid fibril protein AA and the related serum protein SAA. Scand J Immunol (1975) 1.02
Characterization of human serum amyloid A protein isoforms separated by two-dimensional electrophoresis by liquid chromatography/electrospray ionization tandem mass spectrometry. Electrophoresis (1996) 1.01
Amyloidosis in rheumatoid arthritis. Ann Clin Res (1975) 1.01
Ankylosing spondylitis: a comparative study of patients in an epidemiological survey, and those admitted to a department of rheumatology. J Rheumatol (1984) 1.01
Senile cardiac amyloid: demonstration of a unique fibril protein in tissue sections. J Immunol (1978) 1.00
Laxative-induced chronic liver disease. Scand J Gastroenterol (1972) 0.99
Characterization of human amyloid-related protein SAA as a polymorphic protein: association with albumin and prealbumin in serum. Clin Exp Immunol (1981) 0.99
Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA). Clin Exp Immunol (1982) 0.99
Pseudo-exfoliation material--an amyloid-like substance. Exp Eye Res (1973) 0.99
Liver disease--a prominent cause of serum IgE elevation. Clin Exp Immunol (1976) 0.98
Alternative, non-immunoglobulin origin of amyloid fibrils. Nat New Biol (1972) 0.98
Mental health status in systemic lupus erythematosus. Scand J Rheumatol (1995) 0.98
Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study. J Rheumatol (1999) 0.96
The prevalence of ankylosing spondylitis among Norwegian Samis (Lapps). J Rheumatol (1992) 0.96
Structural studies of a carbohydrate-containing immunoglobulin-lambda-light-chain amyloid-fibril protein (AL) of variable subgroup III. Biochem J (1986) 0.96
Transesophageal and transthoracic echocardiography and Doppler-examinations in systemic lupus erythematosus. Scand J Rheumatol (2001) 0.95
Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies. Am J Med (1983) 0.95
Deposition of fibrinogen (FR-antigen) in skin diseases. I. Psoriasis vulgaris and Psoriasis arthropathica (with special reference to heparin-precipitable fraction). Acta Derm Venereol (1975) 0.95
Serum immunoglobulins and organ non-specific antibodies in diseases of the liver. Scand J Gastroenterol (1977) 0.95
Human lymphocyte subpopulations defined by double surface markers. J Lab Clin Med (1978) 0.94
Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis. Clin Exp Immunol (1989) 0.94
Amyloid-related serum protein (SAA) as an indicator of lung infection in cystic fibrosis. Acta Paediatr Scand (1983) 0.94
Smooth muscle antibody in heroin addicts. Ann Intern Med (1975) 0.93
Hyaluronic acid production in vitro by synovial lining cells from normal and rheumatoid joints. Ann Rheum Dis (1985) 0.93
Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines. Scand J Rheumatol (2001) 0.93
A chemical classification of amyloid. Correlation with different clinical types of amyloidosis. Scand J Rheumatol (1980) 0.93
Further structural and antigenic studies of light-chain amyloid proteins. Scand J Immunol (1981) 0.93
The Norwegian multicenter study. Am J Med (1986) 0.92
The complete amino acid sequence of an amyloid fibril protein AA1 of unusual size (64 residues). Biochem Biophys Res Commun (1976) 0.92
Amyloid A in systemic amyloidosis associated with cancer. Cancer Res (1982) 0.92
HLA-B27 and spondyloarthropathy: value for early diagnosis? J Med Genet (1995) 0.92
Peripheral neuropathy in systemic lupus erythematosus--a longitudinal study. Acta Neurol Scand (2001) 0.91
A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis. Clin Rheumatol (1986) 0.91
HLA antigens in palindromic rheumatism, nonerosive rheumatoid arthritis and classical rheumatoid arthritis. J Rheumatol (1984) 0.91
Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses. J Intern Med (1996) 0.91
Immunofluorescence studies in herpes gestationis. Acta Derm Venereol (1975) 0.91
Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study. Rheumatology (Oxford) (2002) 0.91
Glycosylation of immunoglobulin light chains associated with amyloidosis. Amyloid (2000) 0.90
Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I). Clin Exp Immunol (1981) 0.90
Individual antigenic specificity and cross-reactions among amyloid preparations from different individuals. Clin Exp Immunol (1972) 0.90
A clinical comparison between males and females with ankylosing spondylitis. J Rheumatol (1985) 0.90
Peripheral neuropathy in systemic lupus erythematosus. Neurology (1991) 0.90
The amino acid sequence of an amyloid fibril protein AA isolated from the horse. Scand J Immunol (1987) 0.90
Clinical, epidemiologic, and therapeutic aspects of ankylosing spondylitis. Curr Opin Rheumatol (1998) 0.89
Clinical neurological, electrophysiological, and cerebral CT scan findings in systemic lupus erythematosus. Scand J Rheumatol (1989) 0.89
The primary structure of amyloid fibril protein AA in endotoxin-induced amyloidosis of the mink. Eur J Biochem (1980) 0.89